Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Petillo

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Giornale Italiano Di Cardiologia|December 1, 1984
[Acute dissection of the thoracic aorta. Proposal of a new surgical technic]S Spagnolo, V Dottori, E Micalizzi, et al.
Archives of Biochemistry and Biophysics|May 5, 2023
Structure of Rhizobium sp. 4-9 histamine dehydrogenase and analysis of the electron transfer pathway to an abiological electron acceptorPriyanka Goyal, Dwight Deay, Steve Seibold, et al.
Sleep|September 4, 2012
Lactate as a biomarker for sleepErik Naylor, Daniel V Aillon, Brian S Barrett, et al.
Lab on a Chip|August 5, 2024
Patterned thin film enzyme electrodes <i>via</i> spincoating and glutaraldehyde vapor crosslinking: towards scalable fabrication of integrated sensor-on-CMOS devicesDvin Adalian, Xiomi Madero, Samson Chen, et al.
Cancer Research|April 21, 2011
The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABLT315I and exhibits a narrow resistance profileChristopher A Eide, Lauren T Adrian, Jeffrey W Tyner, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge regionYu Mi Ahn, Michael Clare, Carol L Ensinger, et al.
Cancer Cell|April 13, 2011
Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036Wayne W Chan, Scott C Wise, Michael D Kaufman, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Giornale Italiano Di Cardiologia|December 1, 1984
[Acute dissection of the thoracic aorta. Proposal of a new surgical technic]S Spagnolo, V Dottori, E Micalizzi, et al.
Archives of Biochemistry and Biophysics|May 5, 2023
Structure of Rhizobium sp. 4-9 histamine dehydrogenase and analysis of the electron transfer pathway to an abiological electron acceptorPriyanka Goyal, Dwight Deay, Steve Seibold, et al.
Sleep|September 4, 2012
Lactate as a biomarker for sleepErik Naylor, Daniel V Aillon, Brian S Barrett, et al.
Lab on a Chip|August 5, 2024
Patterned thin film enzyme electrodes <i>via</i> spincoating and glutaraldehyde vapor crosslinking: towards scalable fabrication of integrated sensor-on-CMOS devicesDvin Adalian, Xiomi Madero, Samson Chen, et al.
Cancer Research|April 21, 2011
The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABLT315I and exhibits a narrow resistance profileChristopher A Eide, Lauren T Adrian, Jeffrey W Tyner, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge regionYu Mi Ahn, Michael Clare, Carol L Ensinger, et al.
Cancer Cell|April 13, 2011
Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036Wayne W Chan, Scott C Wise, Michael D Kaufman, et al.
Pageof 3